New tissue models could help researchers develop drugs for liver disease

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a buildup of fat in the liver. This condition can lead to the development of more severe liver disease that causes inflammation and fibrosis.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup